CD40LG and COVID-19: Indeed, a previous study that compared the kinetics of SARS-CoV-2-specific IgM and IgG responses in COVID-19 patients suggests that the antibody response was more significant in intensive unit care (ICU) patients than in non-ICU patients during the acute phase of the SARS-CoV-2 infection [15].